GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer
Analytical Cellular Pathology · 30.12.2019 · 2019 · 1-13
DOI: 10.1155/2019/1038069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Cellular Pathology, erschienen am 30.12.2019. Verfasst von Yongchang Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 10073…. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Science and Technology Department, National Natural Science Foundation of China, National Postdoctoral Program for Innovative Talents.
Abstract (Originalsprache)
GTSE1 is well correlated with tumor progression; however, little is known regarding its role in liver cancer prognosis. By analyzing the hepatocellular carcinoma (HCC) datasets in GEO and TCGA databases, we showed that high expression of GTSE1 was correlated with advanced pathologic stage and poor prognosis of HCC patients. To investigate underlying molecular mechanism, we generated GTSE1 knockdown HCC cell line and explored the effects of GTSE1 deficiency in cell growth. Between GTSE1 knockdown and wild-type HCC cells, we identified 979 differentially expressed genes (520 downregulated and 459 upregulated genes) in the analysis of microarray-based gene expression profiling. Functional enrichment analysis of DEGs suggested that S phase was dysregulated without GTSE1 expression, which was further verified from flow cytometry analysis. Moreover, three other DEGs: CDC20, PCNA, and MCM6, were also found contributing to GTSE1-related cell cycle arrest and to be associated with poor overall survival of HCC patients. In conclusion, GTSE1, together with CDC20, PCNA, and MCM6, may synergistically promote adverse prognosis in HCC by activating cell cycle. Genes like GTSE1, CDC20, PCNA, and MCM6 may be promising prognostic molecular biomarkers in liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
- Center of Tree Shrew Germplasm Resources, Institute of Medical Biology, The Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infec…
- Department of Hepatobiliary Surgery, Affiliated Hospital of Guizhou Medical University, No. 28, Guiyi Street, Yunyan District, 550004 Guiyang, China.
- MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, Bioinformatics Division, BNRist, Department of Automation, Tsinghua University, Beijing 100084, China.
- Department of Basic Medical Science, Tsinghua-Peking Joint Center for Life Sciences, School of Medicine, Tsinghua University, Beijing 100084, China.
ORCID-Profile: Yongchang Zheng, Yue Shi, Si Yu, Yang Chen, Jingyu Wang
Förderung
- Guizhou Science and Technology Department
- National Natural Science Foundation of China
- National Postdoctoral Program for Innovative Talents
- Beijing Municipal Natural Science Foundation
- Beijing Municipal Science and Technology Commission
Zitieren
APA
Zheng, Y., Shi, Y., Yu, S., Han, Y., Kang, K., Xu, H., Gu, H., Sang, X., Chen, Y., & Wang, J. (2019). GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer. Analytical Cellular Pathology, 2019, 1-13. https://doi.org/10.1155/2019/1038069
Vancouver
Zheng Y, Shi Y, Yu S, Han Y, Kang K, Xu H, et al. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer. Analytical Cellular Pathology. 2019;2019:1-13. doi:10.1155/2019/1038069
BibTeX
@article{Zheng2019,
author = {Zheng, Yongchang and Shi, Yue and Yu, Si and Han, Yuanyuan and Kang, Kai and Xu, Haifeng and Gu, Huajian and Sang, Xinting and Chen, Yang and Wang, Jingyu},
title = {GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer},
journal = {Analytical Cellular Pathology},
year = {2019},
volume = {2019},
pages = {1--13},
doi = {10.1155/2019/1038069}
}
EUVIMED